Latest Insider Transactions at Pax Medica, Inc. (PXMD)
This section provides a real-time view of insider transactions for Pax Medica, Inc. (PXMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PaxMedica, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PaxMedica, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 26
2023
|
Michael Derby > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
6,272
-1.32%
|
$6,272
$1.61 P/Share
|
|
Apr 13
2023
|
Charles J Casamento Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+17.59%
|
-
|
|
Apr 13
2023
|
John F Coelho Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+14.7%
|
-
|
|
Apr 13
2023
|
Michael Derby > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+24.02%
|
-
|
|
Apr 13
2023
|
Karen La Rochelle Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+19.88%
|
-
|
|
Apr 13
2023
|
Zachary Rome Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+20.47%
|
-
|
|
Apr 13
2023
|
Stephen Sheldon CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+28.57%
|
-
|
|
Apr 13
2023
|
Howard J. Weisman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
180,000
+19.96%
|
-
|
|
Mar 09
2023
|
John F Coelho Director |
SELL
Open market or private sale
|
Direct |
130
-0.19%
|
$130
$1.48 P/Share
|
|
Mar 09
2023
|
Karen La Rochelle Director |
SELL
Open market or private sale
|
Direct |
335
-0.78%
|
$335
$1.48 P/Share
|
|
Mar 09
2023
|
Michael Derby > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,143
-0.66%
|
$2,143
$1.43 P/Share
|
|
Mar 09
2023
|
Zachary Rome Director |
SELL
Open market or private sale
|
Direct |
3,371
-1.16%
|
$3,371
$1.44 P/Share
|
|
Mar 09
2023
|
Howard J. Weisman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,495
-0.64%
|
$3,495
$1.44 P/Share
|
|
Mar 08
2023
|
Zachary Rome Director |
SELL
Open market or private sale
|
Direct |
30,034
-9.33%
|
$30,034
$1.47 P/Share
|
|
Mar 08
2023
|
Howard J. Weisman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
32,397
-5.61%
|
$32,397
$1.46 P/Share
|
|
Mar 07
2023
|
Michael Derby > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,134
-4.43%
|
$15,134
$1.55 P/Share
|
|
Mar 07
2023
|
Zachary Rome Director |
SELL
Open market or private sale
|
Direct |
23,432
-6.79%
|
$23,432
$1.53 P/Share
|
|
Mar 07
2023
|
Howard J. Weisman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,551
-3.92%
|
$23,551
$1.53 P/Share
|
|
Mar 06
2023
|
Michael Derby > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,828
-3.89%
|
$13,828
$1.72 P/Share
|
|
Mar 06
2023
|
Zachary Rome Director |
SELL
Open market or private sale
|
Direct |
13,560
-3.78%
|
$13,560
$1.72 P/Share
|
|
Mar 06
2023
|
Howard J. Weisman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,589
-2.21%
|
$13,589
$1.72 P/Share
|
|
Mar 03
2023
|
Michael Derby > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
18,968
-5.06%
|
$18,968
$1.9 P/Share
|
|
Mar 03
2023
|
Zachary Rome Director |
SELL
Open market or private sale
|
Direct |
13,199
-3.55%
|
$13,199
$1.89 P/Share
|
|
Mar 03
2023
|
Howard J. Weisman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,323
-2.43%
|
$15,323
$1.9 P/Share
|
|
Mar 03
2023
|
Karen La Rochelle Director |
SELL
Open market or private sale
|
Direct |
1,097
-2.5%
|
$1,097
$1.9 P/Share
|
|
Mar 02
2023
|
Michael Derby > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,497
-2.73%
|
$10,497
$1.94 P/Share
|
|
Mar 02
2023
|
Zachary Rome Director |
SELL
Open market or private sale
|
Direct |
12,952
-3.36%
|
$12,952
$1.94 P/Share
|
|
Mar 02
2023
|
Howard J. Weisman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,679
-1.82%
|
$11,679
$1.94 P/Share
|
|
Mar 02
2023
|
Karen La Rochelle Director |
SELL
Open market or private sale
|
Direct |
7,736
-15.0%
|
$7,736
$1.94 P/Share
|
|
Mar 02
2023
|
John F Coelho Director |
SELL
Open market or private sale
|
Direct |
3,013
-4.28%
|
$3,013
$1.93 P/Share
|
|
Nov 19
2022
|
Stephen Sheldon CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct |
135,000
+47.37%
|
-
|
|
Oct 01
2022
|
Charles J Casamento Director |
BUY
Grant, award, or other acquisition
|
Direct |
51,583
+50.0%
|
-
|
|
Aug 30
2022
|
Tardi Med Sciences LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
95,000
+1.28%
|
$475,000
$5.25 P/Share
|
|
Aug 30
2022
|
Michael Derby > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
95,000
+1.28%
|
$475,000
$5.25 P/Share
|